POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma

Radiotherapy is the primary means of treatment for patients with head and neck squamous cell carcinoma (HNSCC); however, radioresistance-induced recurrence is the primary cause of HNSCC treatment failure. Therefore, identifying specific predictive biomarkers of the response to radiotherapy may impro...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xu, Xu, Hongfa, Zhao, Wei, Zhan, Meixiao, Li, Yong, Liu, Hongyi, Tan, Li, Lu, Ligong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781657/
https://www.ncbi.nlm.nih.gov/pubmed/31612055
http://dx.doi.org/10.3892/ol.2019.10888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781657/
https://www.ncbi.nlm.nih.gov/pubmed/31612055
http://dx.doi.org/10.3892/ol.2019.10888

Ejemplares similares